Research16. September 2021 2022-05-31 14:49
The Research Unit delivers results at a high level of international research, and works from both a Danish and European research perspective via the European League Against Rheumatism (EULAR) Research Roadmap, RheumaMap.
The overall aim of the research unit is to investigate and develop strategies for the identification and treatment of patients with inflammatory rheumatic diseases, focusing principally on rheumatoid arthritis, spinal arthritis and psoriatic arthritis.
The Research Unit conducts both pharmacological and non-pharmacological research and involves patients as research partners, with the aim of developing individual treatment according to the patient’s physical, psychological and social situation.
New projects are continually being launched. In these years, there is a focus on cannabis and its possibly positive effect on pain. The Research Unit and The Danish Centre for Expertise in Rheumatology have initiated a research study that runs over three years. A group of patients is being followed, where half receive a cannabis product and the other half receive a placebo drug.
The Research Unit is located side by side with the laboratory and outpatient clinic and is fully integrated into the operations of the entire hospital. This means that the path from new knowledge to clinical practice is short and direct. Three professors are employed at the unit, two of whom focus on rehabilitation. In addition, there are associate professors and Ph.D. students.